IOVA — Iovance Biotherapeutics, Inc.

IOVAIovance Biotherapeutics, Inc.

NAS · US · Healthcare · Biotechnology · iovance.com

4.020USD-2.19%Mkt Cap: 1.82B USDP/E: —Last update: 2026-05-26

Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other so…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap1.82B USD

Enterprise Value1.39B USD

Revenue (TTM)285.61M USD

Gross Profit90.32M USD

Net Income (TTM)-390.98M USD

Revenue/Share0.7490 USD

Last Price4.020 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees975

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-11.08

PEG—

EV/EBITDA-4.31

EV/Revenue4.85

P/S5.78

P/B2.25

EPS (TTM)-0.92

EPS (Forward)-0.33

52W Range

1.66059% of range5.630

52W High5.630 USD

52W Low1.660 USD

Profitability

Gross Margin34.28%

Oper. Margin-113.46%

EBITDA Margin-112.61%

Profit Margin-148.38%

ROE-55.97%

ROA-42.82%

Growth

Revenue Growth44.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF-302.41M USD

CapEx (TTM)33.84M USD

FCF Margin-52.19%

FCF Yield-8.21%

Net Debt-265.67M USD

Net Debt/EBITDA0.83

Balance Sheet

Debt/Equity0.07

Current Ratio3.60

Quick Ratio3.05

Book Value/Sh1.647 USD

Cash/Share0.7020 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:100

Split DateSep 26, 2013

Analyst Consensus

Rating1.6 (Buy)

Target (Mean)8.800 USD

Target Range4.000 USD – 14.00 USD

# Analysts10

Ownership

Shares Out.446.50M

Float387.98M

Insiders0.33%

Institutions67.41%

Short Interest

Short Ratio8.1d

Short % Float27.50%

Short % Out.25.69%

Shares Short114.71M

Short (prev mo.)110.83M

Technical

SMA 503.629 (+10.8%)

SMA 2002.814 (+42.9%)

Beta0.69

S&P 52W Chg28.31%

Avg Vol (30d)14.50M

Avg Vol (10d)12.74M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—